1.12
price down icon0.88%   -0.010
pre-market  Pre-market:  1.13   0.010   +0.89%
loading
Repare Therapeutics Inc stock is traded at $1.12, with a volume of 173.37K. It is down -0.88% in the last 24 hours and down -6.67% over the past month. Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$1.13
Open:
$1.11
24h Volume:
173.37K
Relative Volume:
0.39
Market Cap:
$47.61M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.5022
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
-5.88%
1M Performance:
-6.67%
6M Performance:
-68.27%
1Y Performance:
-79.26%
1-Day Range:
Value
$1.09
$1.17
1-Week Range:
Value
$1.09
$1.25
52-Week Range:
Value
$1.06
$5.66

Repare Therapeutics Inc Stock (RPTX) Company Profile

Name
Name
Repare Therapeutics Inc
Name
Phone
(857) 412-7018
Name
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Name
Employee
129
Name
Twitter
@reparerx
Name
Next Earnings Date
2023-08-09
Name
Latest SEC Filings
Name
RPTX's Discussions on Twitter

Compare RPTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RPTX
Repare Therapeutics Inc
1.12 47.61M 51.13M -93.80M -129.10M -2.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-09-23 Upgrade Stifel Hold → Buy
Feb-03-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-06-23 Initiated CapitalOne Overweight
Apr-12-22 Downgrade Stifel Buy → Hold
Mar-17-22 Resumed Goldman Buy
Sep-23-21 Initiated Stifel Buy
Sep-13-21 Initiated H.C. Wainwright Buy
Jun-28-21 Initiated Guggenheim Buy
Mar-01-21 Initiated Berenberg Buy
Oct-28-20 Initiated Northland Capital Outperform
Jul-14-20 Initiated Cowen Outperform
Jul-14-20 Initiated Goldman Neutral
Jul-14-20 Initiated Morgan Stanley Overweight
Jul-14-20 Initiated Piper Sandler Overweight
View All

Repare Therapeutics Inc Stock (RPTX) Latest News

pulisher
Mar 11, 2025

HC Wainwright Issues Pessimistic Forecast for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat

Mar 11, 2025
pulisher
Mar 11, 2025

What Makes Repare Therapeutics (RPTX) a New Buy Stock - Yahoo Finance

Mar 11, 2025
pulisher
Mar 07, 2025

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bluefield Daily Telegraph

Mar 07, 2025
pulisher
Mar 07, 2025

New Hires at Repare Get Stock Options as Share Price Shows 67% Drop - StockTitan

Mar 07, 2025
pulisher
Mar 07, 2025

Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace

Mar 07, 2025
pulisher
Mar 07, 2025

Repare Therapeutics stock target cut to $5 at H.C. Wainwright - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Repare Therapeutics stock target cut to $5 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

symbol__ Stock Quote Price and Forecast - CNN

Mar 07, 2025
pulisher
Mar 07, 2025

Repare Therapeutics (NASDAQ:RPTX) Announces Quarterly Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat

Mar 07, 2025
pulisher
Mar 04, 2025

Here's Why We're Watching Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Repare Therapeutics Focuses on Clinical Trials Amid Restructuring - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Repare Therapeutics Restructures and Focuses on Key Clinical Trials - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - CRISPR Medicine News

Mar 03, 2025
pulisher
Mar 03, 2025

Repare Therapeutics anticipates key trial results by late 2025 - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Repare Therapeutics Inc. SEC 10-K Report - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Repare Therapeutics reports Q4 EPS (67c), consensus (79c) - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Can Repare Therapeutics' Massive 75% Staff Cut Save Its Clinical Pipeline? - StockTitan

Mar 03, 2025
pulisher
Mar 02, 2025

Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Sold by ARK Investment Management LLC - MarketBeat

Mar 02, 2025
pulisher
Feb 28, 2025

Repare Therapeutics stock hits 52-week low at $1.06 By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 27, 2025

Repare Therapeutics stock hits 52-week low at $1.06 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Repare Therapeutics cuts 75% of workforce - MSN

Feb 27, 2025
pulisher
Feb 26, 2025

Repare Therapeutics to cut 75% of workforce in major restructuring - The Pharma Letter

Feb 26, 2025
pulisher
Feb 26, 2025

Parp Inhibitor Market Future Business Opportunities 2025-2032 - openPR

Feb 26, 2025
pulisher
Feb 25, 2025

Repare Therapeutics to cut staff again, this time by 75% - PharmaLive

Feb 25, 2025
pulisher
Feb 25, 2025

Cambridge-Montreal biotech lets go 75% of employees - The Business Journals

Feb 25, 2025
pulisher
Feb 25, 2025

Repare Therapeutics Chief Medical Officer to Leave -February 25, 2025 at 01:10 pm EST - Marketscreener.com

Feb 25, 2025
pulisher
Feb 25, 2025

Repare Therapeutics Announces Major Reorganization in 2025 - TipRanks

Feb 25, 2025
pulisher
Feb 23, 2025

Repare Therapeutics Inc. (NASDAQ:RPTX) Stock Holdings Lifted by Vontobel Holding Ltd. - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

Repare Therapeutics (RPTX) to Release Earnings on Wednesday - MarketBeat

Feb 22, 2025
pulisher
Feb 20, 2025

Repare Therapeutics Inc. (RPTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

Repare Therapeutics Stock Hits 52-Week Low at $1.2 Amid Market Challenges - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

Repare Therapeutics (RPTX) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Feb 19, 2025

Repare Therapeutics Inc Stock (RPTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):